Kalra Sanjay, Aggarwal Sameer, Kumar Ashok
Consultant Endocrinologist, BRIDE Hospital, Karnal, Haryana, India.
Consultant Endocrinologist, Apex Plus Super Speciality Hospital, Rohtak, Haryana, India.
Turk Arch Pediatr. 2021 Sep;56(5):411-414. doi: 10.5152/TurkArchPediatr.2021.0126.
Growth hormone (GH) therapy is an integral part of the treatment of short stature. Over the period of the last few decades, due to the better availability of recombinant human growth hormone (rHGH), we have more clinical data on the uses of GH in various diseases. The list of approved uses of the GH apart from the classical growth hormone deficiency (GHD) is increasing and is much longer than before but still, adherence to therapy is poor as seen in other chronic diseases also. In this review, we plan to discuss the means of better communication and counseling of the patient to ensure adequate adherence to therapy for optimal clinical outcome.
生长激素(GH)疗法是治疗身材矮小的重要组成部分。在过去几十年中,由于重组人生长激素(rHGH)的可获得性提高,我们有了更多关于GH在各种疾病中应用的临床数据。除了经典的生长激素缺乏症(GHD)外,GH的批准用途列表正在增加,且比以前长得多,但与其他慢性病一样,治疗依从性仍然很差。在本综述中,我们计划讨论更好地与患者沟通和咨询的方法,以确保充分的治疗依从性,从而获得最佳临床结果。